Tesamorelin is dosed once daily, and the exact number depends on the formulation. The pivotal HIV lipodystrophy trials and the original Egrifta used 2 mg subcutaneously daily, while the reformulated EGRIFTA SV label specifies 1.4 mg once daily. It is the same molecule at different reconstituted concentrations.[1][2][3]
Reviewed for accuracy · Last reviewed July 7, 2026It is dosed daily rather than weekly because GHRH analogs are cleared quickly, and a daily injection maintains the intended pattern of the body's own growth-hormone release. In the trials, cycles ran for months, and the effect on visceral fat generally reversed after the compound was stopped.
This page is an independent educational reference and is not medical advice. Talk to a doctor before starting any compound.